IMMUNETHEP

About:

Immunethep is a biotech startup company that is developing broad coverage anti-bacterial immunotherapies

Website: http://www.immunethep.com

Top Investors: European Innovation Council, Bill & Melinda Gates Foundation, Portugal Ventures, Venture Catalysts

Description:

Immunethep is a biotechnology company focused on drug development for Immune System related pathologies. Immunethep is a spin-off from the University of Porto that uses its proprietary technology to address unmet medical needs. Immunethep discovered a novel mechanism used by different pathogenic bacteria to suppress host immune response. By targeting this mechanism we are developing broad coverage anti-bacterial immunotherapies.

Total Funding Amount:

$2.57M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cantanhede, Coimbra, Portugal

Founded Date:

2013-10-16

Contact Email:

info(AT)immunethep.com

Founders:

Agostinho João Almeida, Bruno Santos, Hugo Ramos, João Ferreira, Pedro Madureira, Rafael Simão

Number of Employees:

1-10

Last Funding Date:

2022-10-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai